Her-2/Neu Oncoprotein (IHC)

HER2/neu testing is crucial for identifying HER2-positive breast cancer, which may respond to targeted therapies like trastuzumab. It helps assess prognosis and determine treatment options.

Also known asHER2 IHC TestHER2 ImmunohistochemistryERBB2 Protein ExpressionHER2 Protein Status

Available via

Home Collection, Lab Visit

Contains

5 parameters

Earliest reports in

7 Working Days

Test details
Preparations

No special preparations needed

Test included
Her-2/Neu Oncoprotein (IHC) includes 5 parameters

  • Request Letter
  • Additional Communication
  • Specimen
  • Microscopy
  • Her2/neu Oncoprotein

Test code

Z004K

Specimen vol. and vacutainer information
SpecimenVacutainerVolume
Paraffin BlockOthers100 MG
TissueOthers10

Specimen stability information

Paraffin Block, Tissue

Collection instructions

Tissue In 10% Neutral Buffered Formalin For 24-48 Hrs/ Paraffin Block+ Site Of Biopsy , Clinical Details & Primary Histopathology Report Mandatory. If Tissue Received It Will Be Charged For Tissue Processing.* Time And Duration Of Fixation Should Be Mentioned On The TRF.*

Specimen rejection criteria

Test run frequency

Every Day TIME - 11:00

Turn around time

7 Working Days

Performing locations

Department

  • Histopath

CPT and Loinc codes

Her-2/Neu Oncoprotein (IHC)

2500